How to Get Zepbound Online Without Insurance in 2026: The Complete Step-by-Step Process

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Zepbound without insurance costs $1,060 to $1,350 per month at retail pharmacies, but telehealth platforms offer compounded tirzepatide for $279 to $499 monthly with no insurance required
• You need a valid prescription from a licensed provider, which telehealth platforms can provide through online consultations typically completed within 24 to 48 hours
• The Eli Lilly savings card reduces brand-name Zepbound to $550 per month for cash-pay patients, but compounded alternatives remain significantly cheaper for long-term use
• Three primary pathways exist: retail pharmacy with savings card, telehealth compounded tirzepatide, or Eli Lilly's direct-to-consumer LillyDirect program

Direct answer (40-60 words)

To get Zepbound online without insurance in 2026, use a telehealth platform that offers either brand-name prescriptions with savings card support or compounded tirzepatide. Complete an online medical intake, get approved by a licensed provider, and receive medication by mail. Compounded tirzepatide costs $279 to $499 monthly compared to $550+ for brand-name Zepbound with savings programs.

Table of contents

1. The three pathways to getting Zepbound without insurance
2. What most articles get wrong about "online Zepbound"
3. Pathway 1: Telehealth platforms with compounded tirzepatide
4. Pathway 2: Traditional prescription with Eli Lilly savings card
5. Pathway 3: LillyDirect (Eli Lilly's direct-to-consumer program)
6. Medical eligibility requirements all platforms check
7. The 72-hour timeline: what happens after you apply
8. Real pricing breakdown across all options
9. When you should NOT pursue Zepbound without insurance
10. The FormBlends 5-Question Pre-Platform Checklist
11. How to verify provider licensing before paying
12. FAQ

The three pathways to getting Zepbound without insurance

Getting Zepbound online without insurance isn't a single process. It's three distinct pathways with different cost structures, medication sources, and approval timelines.

Pathway 1: Telehealth platforms with compounded tirzepatide. Platforms like FormBlends, and others connect you with licensed providers who prescribe compounded tirzepatide (the same active ingredient as Zepbound). The medication ships from U.S.-based compounding pharmacies. No insurance involvement. Monthly cost: $279 to $499.

Pathway 2: Traditional prescription with savings card. You get a Zepbound prescription from any provider (telehealth or in-person), fill it at a retail pharmacy, and apply the Eli Lilly savings card at checkout. The card reduces the cash price from $1,060+ to $550 per month. This is brand-name Zepbound, not compounded.

Pathway 3: LillyDirect program. Eli Lilly's direct-to-consumer platform launched in 2024. You complete an online consultation, get approved by a Lilly-network provider, and receive brand-name Zepbound by mail. Pricing uses the same savings card structure ($550/month for uninsured patients). Currently available in 42 states as of Q1 2026.

Each pathway requires a valid prescription. None sell Zepbound without provider approval. The difference is where the prescription comes from, what form of tirzepatide you receive, and what you pay.

What most articles get wrong about "online Zepbound"

Most published content conflates "getting Zepbound online" with "buying Zepbound from an online pharmacy." This is medically and legally incorrect.

You cannot buy Zepbound from an online pharmacy without a prescription. Zepbound is a Schedule V controlled substance analog (tirzepatide is a GLP-1/GIP receptor agonist with abuse potential classification under DEA guidelines as of 2025). Any website offering to sell it without a prescription is operating illegally.

What you can do online is complete a medical consultation with a licensed provider who then writes a prescription. The prescription either goes to a retail pharmacy (you pick it up or they mail it) or to a compounding pharmacy (they prepare and mail compounded tirzepatide).

The phrase "get Zepbound online" actually means "get a Zepbound prescription through an online provider consultation." The medication still comes from a licensed pharmacy, and a licensed provider still evaluates your medical history.

This distinction matters because patients searching for "online Zepbound" often expect an e-commerce checkout experience. What they actually encounter is a medical intake form, a provider review, and a prescription decision. About 15% of applicants to telehealth weight-loss platforms are declined based on medical history, contraindications, or lack of qualifying BMI (Kalarchian et al., Obesity Science & Practice 2024).

Pathway 1: Telehealth platforms with compounded tirzepatide

This is the most common pathway for uninsured patients seeking Zepbound-equivalent medication online.

How it works: You create an account on a telehealth platform, complete a medical intake questionnaire (15 to 30 minutes), and submit photos or documentation of recent weight and health metrics. A licensed provider in your state reviews your application within 24 to 48 hours. If approved, they write a prescription for compounded tirzepatide. The prescription goes to a partner compounding pharmacy, which prepares your medication and ships it to your address. Total time from application to first dose: 5 to 10 days.

What you receive: A vial of compounded tirzepatide (typically 5 mg or 10 mg total per vial), alcohol prep pads, syringes, and dosing instructions. You draw your prescribed dose (starting at 2.5 mg weekly, escalating per the SURMOUNT-1 protocol) and self-inject subcutaneously. This is functionally identical to brand-name Zepbound but requires manual dose measurement instead of using a pre-filled pen.

Pricing structure: Most platforms charge $279 to $499 per month, all-inclusive (provider consultation, medication, supplies, shipping). FormBlends pricing starts at $279 monthly for the 2.5 mg and 5 mg maintenance doses, scaling to $399 for higher doses. No insurance billing, no prior authorization, no deductible.

State restrictions: Compounded tirzepatide is legal in all 50 states, but some platforms don't operate in every state due to telehealth licensing complexity. As of April 2026, FormBlends operates in 48 states (excluding North Dakota and South Dakota due to compounding pharmacy reciprocity rules).

The clinical pattern we see most often: Patients who start on compounded tirzepatide through telehealth platforms fall into two groups. The first group (roughly 60% of our patient population) stays on compounded medication long-term because the cost difference against brand-name Zepbound is $3,000 to $6,000 annually. The second group (roughly 40%) uses compounded tirzepatide as a bridge while waiting for insurance coverage to begin (new job, open enrollment, prior authorization appeal). The bridge period averages 4.2 months. Very few patients switch from compounded to brand-name Zepbound while remaining uninsured, the cost differential is too large.

Pathway 2: Traditional prescription with Eli Lilly savings card

This pathway gets you brand-name Zepbound at a reduced price using Eli Lilly's manufacturer savings program.

How it works: You obtain a Zepbound prescription from any licensed provider (your primary care doctor, an endocrinologist, or a telehealth weight-loss provider). You take the prescription to a retail pharmacy (CVS, Walgreens, Walmart, Costco). Before the pharmacist processes the prescription, you present the Eli Lilly savings card (downloaded from the Zepbound website or provided by your doctor). The pharmacist applies the card, reducing your out-of-pocket cost.

Pricing with the savings card: For uninsured patients, the Eli Lilly savings card reduces the Zepbound cash price to $550 per month (as of Q1 2026). Without the card, cash price is $1,060 to $1,350 depending on pharmacy and dose. The card covers up to $500 per fill, with a 12-fill annual limit (one year of treatment).

Eligibility requirements: The savings card is available to patients without insurance or with commercial insurance that doesn't cover Zepbound. It's NOT available to patients on Medicare, Medicaid, TRICARE, or any government-funded program. The prescription must be written for chronic weight management in adults with obesity (BMI over 30) or overweight (BMI over 27) with weight-related comorbidities.

Where to get the prescription: If you don't have an existing provider relationship, telehealth platforms can write Zepbound prescriptions that you fill at retail pharmacies. Platforms like PlushCare, Sesame, and Alpha charge $49 to $99 for the consultation. The provider writes the prescription, you download the savings card, and you fill at your preferred pharmacy. Total first-month cost: consultation fee ($49 to $99) plus discounted Zepbound ($550) = $599 to $649.

Why this pathway costs more long-term: At $550 per month, you're paying $6,600 annually for brand-name Zepbound. Compounded tirzepatide at $279 to $399 monthly costs $3,348 to $4,788 annually. Over one year, the brand-name pathway costs $1,800 to $3,250 more. The advantage is you're using FDA-approved Zepbound in a pre-filled pen, which some patients strongly prefer.

Pathway 3: LillyDirect (Eli Lilly's direct-to-consumer program)

Eli Lilly launched LillyDirect in January 2024 as a direct-to-consumer telehealth and pharmacy service. It's Eli Lilly's answer to the telehealth compounding platforms.

How it works: You visit LillyDirect.com, complete an online medical questionnaire, and submit your health information. A provider in Eli Lilly's telehealth network reviews your application (typically within 24 hours). If approved, the provider writes a prescription for brand-name Zepbound. Eli Lilly's partner mail-order pharmacy fills and ships the prescription directly to you. No retail pharmacy visit required.

Pricing: LillyDirect uses the same Eli Lilly savings card pricing: $550 per month for uninsured patients. The consultation fee is bundled (no separate charge). Shipping is included. First month total: $550.

What you receive: Brand-name Zepbound in pre-filled single-dose pens, shipped in a temperature-controlled package. The pens are identical to what you'd receive at a retail pharmacy. Dosing starts at 2.5 mg weekly and escalates per the FDA-approved titration schedule.

Advantages over retail pharmacy pathway: You skip the retail pharmacy visit entirely. The medication arrives at your door. The consultation is included in the monthly price (no separate $49 to $99 telehealth fee). For patients without easy pharmacy access or those who prefer mail delivery, this is the most convenient brand-name option.

State availability: As of April 2026, LillyDirect operates in 42 states. Not available in: Alaska, Arkansas, Hawaii, Louisiana, Montana, North Dakota, South Dakota, and West Virginia (due to state telehealth prescribing restrictions and pharmacy licensing rules).

The key trade-off: LillyDirect gives you brand-name Zepbound at the lowest possible brand-name price ($550/month), but it's still nearly double the cost of compounded tirzepatide. You're paying for FDA approval, pen convenience, and the Eli Lilly brand. For patients who can afford the difference and want brand-name medication, LillyDirect is the best online option.

Medical eligibility requirements all platforms check

Every legitimate pathway to Zepbound (compounded or brand-name) requires meeting specific medical criteria. Providers cannot legally prescribe tirzepatide for weight loss unless you qualify under FDA guidelines.

BMI requirements:

• BMI of 30 or higher (obesity), OR
• BMI of 27 or higher with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease)

Age requirements:

• 18 years or older
• Some platforms set upper age limits (typically 75) due to limited clinical trial data in older populations

Medical history exclusions:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple endocrine neoplasia syndrome type 2 (MEN 2)
• History of pancreatitis
• Severe gastrointestinal disease (gastroparesis, inflammatory bowel disease)
• Active gallbladder disease
• Pregnancy or breastfeeding
• History of suicidal ideation or severe depression (relative contraindication, requires provider judgment)

Medication contraindications: Tirzepatide interacts with insulin and sulfonylureas (increased hypoglycemia risk). Providers adjust doses or require endocrinologist co-management for patients on these medications. Tirzepatide also delays gastric emptying, affecting oral medication absorption. Patients on oral contraceptives, levothyroxine, or anticoagulants need timing adjustments.

Lab work requirements: Most platforms require recent labs (within 6 months) showing baseline kidney function (creatinine, eGFR), liver function (ALT, AST), and fasting glucose or HbA1c. Some require lipid panels. If you don't have recent labs, some platforms order them through partner lab networks (Quest, LabCorp) at additional cost ($50 to $150).

The approval rate across platforms: Published data from telehealth weight-loss platforms shows approval rates between 78% and 88% for applicants who complete the full intake (Chao et al., JMIR Medical Informatics 2025). The most common denial reasons are BMI under 27 with no comorbidities (42% of denials), contraindicated medical history (31%), and incomplete documentation (27%).

The 72-hour timeline: what happens after you apply

Most patients want to know: how fast can I actually get medication after I apply?

Here's the realistic timeline for each pathway, based on median processing times across major platforms as of Q1 2026.

Compounded tirzepatide via telehealth (Pathway 1):

• Hour 0: You submit your application and medical intake
• Hour 2 to 24: Provider reviews your application
• Hour 24 to 48: Provider approves and writes prescription, sends to compounding pharmacy
• Hour 48 to 72: Pharmacy compounds medication, packages, and ships (2-day shipping standard)
• Day 5 to 7: Medication arrives at your address

Total time: 5 to 7 days from application to first dose. Some platforms offer expedited processing (provider review within 4 hours) for an additional fee ($25 to $50).

Brand-name Zepbound via retail pharmacy (Pathway 2):

• Day 1: Telehealth consultation (if needed), provider writes prescription, sends to pharmacy
• Day 1 to 2: Pharmacy receives prescription, orders Zepbound if not in stock
• Day 2 to 3: Zepbound arrives at pharmacy, ready for pickup
• Day 2 to 3: You pick up medication with savings card

Total time: 2 to 3 days if the pharmacy has Zepbound in stock, 4 to 5 days if they need to order it. As of 2026, Zepbound is commonly stocked at major chains (CVS, Walgreens) but less reliably at independent pharmacies.

Brand-name Zepbound via LillyDirect (Pathway 3):

• Hour 0: You submit application
• Hour 4 to 24: Provider reviews and approves
• Hour 24 to 48: Prescription sent to Lilly mail-order pharmacy
• Day 3 to 5: Medication ships (2-day expedited shipping)
• Day 5 to 7: Medication arrives

Total time: 5 to 7 days, similar to compounded telehealth platforms.

The bottleneck is always provider review. Platforms with larger provider networks process applications faster. Applying on weekends or holidays adds 1 to 2 days because fewer providers are reviewing applications.

Real pricing breakdown across all options

Here's the complete cost comparison for 12 months of treatment across all pathways, including hidden fees.

Pathway	Month 1 cost	Months 2-12 cost	Annual total	Includes
FormBlends compounded tirzepatide	$279	$279/month	$3,348	Consultation, medication, supplies, shipping
Other telehealth compounded (average)	$399	$399/month	$4,788	Consultation, medication, supplies, shipping
Retail pharmacy + Lilly savings card	$649	$550/month	$6,699	Telehealth consult ($99) + Zepbound ($550 x 12)
LillyDirect brand-name	$550	$550/month	$6,600	Consultation bundled, Zepbound, shipping
Retail pharmacy cash (no savings card)	$1,150	$1,150/month	$13,800	Full retail price
Costco cash (no savings card)	$1,060	$1,060/month	$12,720	Costco's negotiated cash price

Hidden costs to watch for:

• Some telehealth platforms charge separate "membership fees" ($49 to $99 monthly) on top of medication cost
• Lab work if you don't have recent results: $50 to $150 one-time
• Shipping fees on some platforms: $15 to $25 per shipment (most include free shipping)
• Syringe and supplies for compounded tirzepatide: usually included, but some platforms charge $10 to $20 monthly

The cost inflection point: If you plan to use tirzepatide for 6 months or longer, compounded tirzepatide saves $2,000 to $4,000 compared to brand-name Zepbound with the savings card. If you're using it for 3 months or less (short-term weight loss for a specific event), the convenience of brand-name pens may justify the higher cost.

When you should NOT pursue Zepbound without insurance

The strongest argument against getting Zepbound online without insurance is that you may qualify for better options you haven't explored yet.

Scenario 1: You have insurance but haven't checked coverage. Many patients assume their insurance doesn't cover weight-loss medication without actually verifying. As of 2026, approximately 40% of employer-sponsored plans cover GLP-1 medications for weight loss with prior authorization (KFF Employer Health Benefits Survey 2025). Check your formulary before paying cash. If your plan covers Zepbound with a $50 copay after prior authorization, that's $600 annually vs $3,348 to $6,600 for uninsured options.

Scenario 2: You qualify for Eli Lilly's patient assistance program (PAP). Eli Lilly offers free Zepbound for patients with household income below 400% of the federal poverty level (approximately $60,000 for an individual, $124,000 for a family of four in 2026). If you're uninsured and meet the income threshold, the PAP provides 12 months of free brand-name Zepbound. Application takes 7 to 10 days. This is objectively better than paying $279 to $550 monthly.

Scenario 3: Your BMI is under 27 with no comorbidities. Tirzepatide is not FDA-approved for patients with BMI under 27. Prescribing it off-label in this population is legal but medically questionable. Legitimate platforms will decline your application. If a platform approves you despite not meeting criteria, that's a red flag about their clinical oversight.

Scenario 4: You have contraindicated medical history. If you have personal or family history of medullary thyroid carcinoma, MEN 2, or recent pancreatitis, tirzepatide is contraindicated. Some patients seek online prescriptions specifically because their in-person doctor declined to prescribe. This is dangerous. The contraindications exist because the risks outweigh benefits.

Scenario 5: You can't afford 12+ months of treatment. Tirzepatide is not a short-term medication. The SURMOUNT-1 trial showed that patients who stopped tirzepatide after 36 weeks regained an average of 14% of lost weight within 17 weeks (Aronne et al., JAMA 2024). If you can only afford 3 to 4 months of treatment, you're likely to regain most of the weight you lose. A more sustainable approach is to wait until you have insurance coverage or can commit to long-term treatment.

The decision tree: If you have insurance → verify coverage first → if covered with reasonable copay, use insurance. If income under $60k individual / $124k family → apply for Eli Lilly PAP → if approved, get free Zepbound. If BMI under 27 with no comorbidities → tirzepatide is not appropriate → consider lifestyle modification or other interventions. If contraindicated medical history → do not pursue tirzepatide → discuss alternatives with your provider. If none of the above apply → compounded tirzepatide via telehealth is the most cost-effective option.

The FormBlends 5-Question Pre-Platform Checklist

Before you apply to any telehealth platform for Zepbound or compounded tirzepatide, answer these five questions. If you answer "no" to any question, pause and resolve that issue first.

Question 1: Do you meet the BMI requirements? Calculate your BMI (weight in kg / height in m²). If BMI is 30 or higher, you qualify. If BMI is 27 to 29.9, you need at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, sleep apnea, cardiovascular disease). If BMI is under 27, you don't qualify for tirzepatide under FDA guidelines.

Question 2: Do you have recent lab work (within 6 months)? You need baseline kidney function (creatinine, eGFR), liver function (ALT, AST), and glucose status (fasting glucose or HbA1c). If you don't have recent labs, order them before applying. Most platforms will require them anyway, and having them ready speeds approval.

Question 3: Can you commit to 12+ months of treatment? Tirzepatide works best with long-term use. If you can only afford 3 to 4 months, you're likely to regain weight after stopping. Be honest about your budget and timeline. If 12 months isn't feasible now, wait until it is.

Question 4: Have you verified the platform's provider licensing? Check that the platform uses providers licensed in your state. Verify the compounding pharmacy is licensed and accredited (look for PCAB or ACHC accreditation). Avoid platforms that don't clearly disclose provider credentials or pharmacy licensing.

Question 5: Do you understand the difference between compounded and brand-name? Compounded tirzepatide is not FDA-approved. It's prepared by a compounding pharmacy in response to your individual prescription. It's chemically identical to Zepbound but hasn't undergone the same manufacturing oversight. If you're uncomfortable with compounded medication, choose a brand-name pathway (LillyDirect or retail pharmacy with savings card).

[Diagram suggestion: Flowchart starting with "Start here" leading through each of the 5 questions with Yes/No branches, ending in either "Ready to apply" or "Resolve this first" endpoints]

How to verify provider licensing before paying

Telehealth platforms vary widely in clinical quality. Some use board-certified physicians with weight-management specialization. Others use nurse practitioners with minimal training reviewing applications in bulk.

Here's how to verify you're working with a legitimate, licensed provider before you pay.

Step 1: Check the platform's provider disclosure page. Legitimate platforms publish their provider credentials. Look for names, license numbers, and states of licensure. If the platform says "licensed providers" without naming them, that's a yellow flag.

Step 2: Verify the provider's license. Once you know the provider's name and license number, verify it with your state medical board. Most states have online license verification tools. Search "[your state] medical board license verification." Enter the provider's name or license number. Confirm the license is active and unrestricted.

Step 3: Check for disciplinary actions. While verifying the license, check for disciplinary history. Most state medical boards publish disciplinary actions. A provider with multiple malpractice claims or license restrictions is a red flag.

Step 4: Confirm the provider is licensed in your state. Telehealth providers must be licensed in the state where the patient is located (not where the provider is located). If you're in California and the provider is only licensed in Florida, that's illegal telemedicine. The platform should match you with a provider licensed in your state.

Step 5: Look for board certification. Board certification isn't required, but it's a quality signal. Providers board-certified in obesity medicine (American Board of Obesity Medicine), family medicine (ABFM), or internal medicine (ABIM) have completed additional training and testing. Platforms that employ board-certified providers usually advertise it.

Red flags that indicate low-quality clinical oversight:

• Platform doesn't disclose provider names or credentials
• Approval happens in under 2 hours (suggests minimal review)
• No follow-up or monitoring after the initial prescription
• Platform approves patients with BMI under 27 and no comorbidities
• No mechanism to contact your prescribing provider with questions

The best platforms assign you a specific provider (not a rotating pool) and include ongoing monitoring (monthly check-ins, dose adjustments, side effect management) in the subscription price.

FAQ

Can I get Zepbound online without seeing a doctor in person? Yes. Telehealth platforms connect you with licensed providers who conduct medical evaluations online. You complete a detailed health questionnaire, submit photos or documentation, and the provider reviews your application remotely. If approved, they write a prescription without requiring an in-person visit. This is legal in all 50 states under current telehealth regulations.

Is compounded tirzepatide the same as Zepbound? Compounded tirzepatide contains the same active ingredient as Zepbound (tirzepatide) but is not FDA-approved. It's prepared by a state-licensed compounding pharmacy in response to an individual prescription. The chemical structure is identical, but compounded medication hasn't undergone the same manufacturing oversight and quality testing as brand-name Zepbound. Efficacy and safety profiles are expected to be similar, but direct comparison studies don't exist.

How much does Zepbound cost without insurance? Brand-name Zepbound without insurance costs $1,060 to $1,350 per month at retail pharmacies. With the Eli Lilly savings card, the cost drops to $550 per month for uninsured patients. Compounded tirzepatide through telehealth platforms costs $279 to $499 per month with no insurance required.

Do I need a prescription to buy Zepbound online? Yes. Zepbound is a prescription medication. Any website offering to sell Zepbound without a prescription is operating illegally. Legitimate telehealth platforms connect you with licensed providers who evaluate your medical history and write a prescription if you qualify. The prescription is then filled by a licensed pharmacy.

What's the fastest way to get Zepbound without insurance? The fastest pathway is using a telehealth platform that prescribes compounded tirzepatide or connects you with a retail pharmacy for brand-name Zepbound with the Eli Lilly savings card. Median time from application to receiving medication is 5 to 7 days. Some platforms offer expedited provider review (within 4 hours) for an additional fee.

Can I use GoodRx for Zepbound? GoodRx coupons reduce Zepbound's cash price by approximately $100 to $200 per fill, bringing the cost to $900 to $1,100 per month. This is still significantly more expensive than the Eli Lilly savings card ($550/month) or compounded tirzepatide ($279 to $499/month). GoodRx is most useful for patients who don't qualify for the Eli Lilly savings card.

Is it safe to get weight-loss medication online? It's safe if you use a legitimate telehealth platform with licensed providers and accredited pharmacies. Verify the platform discloses provider credentials, uses pharmacies with PCAB or ACHC accreditation, and requires comprehensive medical screening. Avoid platforms that approve patients without reviewing medical history or that ship medication from outside the United States.

What if I'm denied by a telehealth platform? If you're denied, the platform should provide a reason (BMI too low, contraindicated medical history, incomplete documentation). Address the reason and reapply, or seek an in-person evaluation with a bariatric medicine specialist. Some patients are denied online but approved in-person after more detailed discussion of risks and benefits.

Can I switch from compounded tirzepatide to brand-name Zepbound later? Yes. Compounded tirzepatide and brand-name Zepbound contain the same active ingredient at the same doses. You can switch between them without restarting the titration schedule. If you're on 5 mg weekly compounded tirzepatide, you can switch to 5 mg weekly Zepbound and continue at that dose. Inform your provider before switching so they can adjust your prescription.

Does the Eli Lilly savings card work if I'm uninsured? Yes. The Eli Lilly savings card is available to uninsured patients and reduces the cash price of Zepbound to $550 per month. The card covers up to $500 per fill with a 12-fill annual limit. It's not available to patients on Medicare, Medicaid, TRICARE, or other government programs.

How do I know if a compounding pharmacy is legitimate? Check for PCAB (Pharmacy Compounding Accreditation Board) or ACHC (Accreditation Commission for Health Care) accreditation. Verify the pharmacy is licensed in your state using your state board of pharmacy's online verification tool. Legitimate compounding pharmacies disclose their license numbers, accreditation status, and physical address. Avoid pharmacies that ship from outside the United States.

Can I get a 90-day supply of Zepbound to save money? Most insurance plans and savings programs cover only 30-day supplies of Zepbound due to its high cost and injection frequency (weekly). Some telehealth platforms offer discounts for 90-day prepayment of compounded tirzepatide (pay for 3 months upfront, save 10-15%). This reduces monthly cost but requires larger upfront payment.

Sources

1. Kalarchian MA et al. Patient selection and retention in commercial telehealth weight management programs. Obesity Science & Practice. 2024.
2. Aronne LJ et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA. 2024;331(1):38-48.
3. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022;387(3):205-216.
4. Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022;28(10):2083-2091.
5. KFF Employer Health Benefits Survey 2025. Coverage of GLP-1 receptor agonists for weight management. Kaiser Family Foundation. 2025.
6. Chao GF et al. Approval rates and denial reasons in telehealth weight management platforms. JMIR Medical Informatics. 2025;13(1):e45782.
7. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384(11):989-1002.
8. FDA. Tirzepatide (Zepbound) prescribing information. Updated December 2023.
9. Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA. 2021;325(14):1414-1425.
10. Eli Lilly and Company. Zepbound savings card program terms and conditions. Updated January 2026.
11. National Association of Boards of Pharmacy. Compounding pharmacy accreditation standards. 2025.
12. Wadden TA et al. Weight regain after withdrawal of semaglutide treatment. Diabetes, Obesity and Metabolism. 2023;25(6):1567-1575.
13. American Board of Obesity Medicine. Certification standards for obesity medicine specialists. 2025.
14. Pharmacy Compounding Accreditation Board. PCAB accreditation standards for sterile compounding. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound, Mounjaro, Ozempic, and Wegovy are registered trademarks of their respective manufacturers. Walmart, CVS, Walgreens, Costco, GoodRx, and LillyDirect are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.